筛选条件 共查询到500条结果
排序方式
Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report

期刊: PHARMACOTHERAPY, 2023; 43 (8)

The presence of extracorporeal membrane oxygenation (ECMO) in addition to underlying critical illness can affect the pharmacokinetics and pharmacodyna......

Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients

期刊: PHARMACOTHERAPY, 2023; 43 (8)

Study Objective: Severe coronavirus disease 2019 (COVID-19) increases the risk of thrombotic complications with unfractionated heparin (UFH) as a comm......

Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors

期刊: PHARMACOTHERAPY, 2023; ()

BackgroundVascular endothelial growth factor inhibitors, including tyrosine kinase inhibitors (TKIs) and anti-angiogenics, are first-line therapies fo......

A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults

期刊: PHARMACOTHERAPY, 2023; 43 (11)

Precision medicine is a growing field in critical care. Research increasingly demonstrated pharmacogenomic variability to be an important determinant ......

From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing

期刊: PHARMACOTHERAPY, 2023; 43 (8)

Antimicrobial stewardship (AMS) programs have been quick to adopt novel molecular rapid diagnostic technologies (mRDTs) for bloodstream infections (BS......

Expanded use of sodium-glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction

期刊: PHARMACOTHERAPY, 2023; 43 (9)

Following the results observed in the DAPA-HF trial and subsequent FDA approval of dapagliflozin in patients living with heart failure with reduced ej......

Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study)

期刊: PHARMACOTHERAPY, 2023; 43 (3)

Study Objective: Aspirin (ASA) has demonstrated inconsistent results in primary prevention of cardiovascular disease (CVD). Guidelines are also incons......

Accelerated approval drug labels often lack information for clinical decision-making

期刊: PHARMACOTHERAPY, 2023; 43 (4)

Study objective: We evaluated US Food and Drug Administration labels for drugs approved under the accelerated approval pathway and whether these label......

External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant

期刊: PHARMACOTHERAPY, 2023; 43 (7)

Study Objective: The immunosuppressant tacrolimus is a first-line agent to prevent graft rejection following pediatric heart transplant; however, it s......

Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation

期刊: PHARMACOTHERAPY, 2023; 43 (1)

Infections of the central nervous system (CNS) are complex to treat and associated with significant morbidity and mortality. Historically, antistaphyl......

Neurokinin-1 receptor antagonists for the prevention of postoperative nausea and vomiting

期刊: PHARMACOTHERAPY, 2023; 43 (9)

Despite the availability of several classes of antiemetics, postoperative nausea and vomiting (PONV) remains a substantial burden for patients followi......

A systematic review of clozapine-associated inflammation and related monitoring

期刊: PHARMACOTHERAPY, 2023; 43 (12)

Clozapine is an effective antipsychotic medication used for treatment-resistant schizophrenia. However, it is underutilized due to rigorous hematologi......

Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline

期刊: PHARMACOTHERAPY, 2023; 43 (4)

Extravasation is the leakage of intravenous solutions into surrounding tissues, which can be influenced by drug properties, infusion techniques, and p......

Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophilia

期刊: PHARMACOTHERAPY, 2023; 43 (8)

Stenotrophomonas maltophilia is an opportunistic pathogen and frequent cause of serious nosocomial infections. Patient populations at greatest risk fo......

共500条页码: 1/34页15条/页